Sagimet Biosciences Inc. Series A Common Stock Dividends
The next dividend date for Sagimet Biosciences Inc. Series A Common Stock has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Sagimet Biosciences Inc. Series A Common Stock (SGMT)
More About Sagimet Biosciences Inc. Series A Common Stock
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
Owning Sagimet Biosciences Inc. Series A Common Stock Stock on the Dividend Date
If you own Sagimet Biosciences Inc. Series A Common Stock stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Sagimet Biosciences Inc. Series A Common Stock stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Sagimet Biosciences Inc. Series A Common Stock stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Sagimet Biosciences Inc. Series A Common Stock stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Sagimet Biosciences Inc. Series A Common Stock dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Sagimet Biosciences Inc. Series A Common Stock Dividends
You can contact us any time if you would like to ask questions about Sagimet Biosciences Inc. Series A Common Stock dividends or anything else related to the stock market.